J. Andersson

Breast cancer screening with mammography: overview of Swedish randomised trials

S. Wall, L. Tabár, G. Fagerberg, 1993, The Lancet.

A Population-based Study on the First Forty-Eight Breast Cancer Patients Receiving Trastuzumab (Herceptin®) on a Named Patient Basis in Sweden

J. Bergh, S. Klaar, L. Tennvall-Nittby, 2002, Acta oncologica.

HER-2/neu (c-erbB-2) Evaluation in Primary Breast Carcinoma by Fluorescent In Situ Hybridization and Immunohistochemistry With Special Focus on Intratumor Heterogeneity and Comparison of Invasive and In Situ Components

J. Bergh, G. Elmberger, B. Linderholm, 2004, Applied immunohistochemistry & molecular morphology : AIMM.

Worse survival for TP53 (p53)-mutated breast cancer patients receiving adjuvant CMF.

L. Holmberg, M. Inganäs, S. Klaar, 2005, Annals of oncology : official journal of the European Society for Medical Oncology.

Can Axillary Dissection be Avoided by Improved Molecular Biological Diagnosis?

J. Bergh, J. Bjöhle, S. Klaar, 2000, Acta oncologica.